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Abstract Objective: Lung injury is
a severe complication of acute pancre-
atitis that increases the mortality rate
of the disease. The pathophysiology
of acute pancreatitis has been studied
in several experimental models, but
the kinetics of pulmonary compli-
cations in relation to the pancreatic
disease is not completely understood.
We then studied the severity of acute
pancreatitis-associated lung injury
over 18 h in rats that had taurocholic
acid injection in the pancreatic duct
and determined whether blood col-
lected from rats with pancreatitis
is toxic enough to induce injury in
normal lungs. Design and setting:
Prospective, randomized, and con-
trolled animal study in an animal
research laboratory in a university
hospital. Interventions: We isolated
lungs from rats with acute pancre-
atitis 2, 6, and 18 h after taurocholic
acid injection in the biliopancreatic
duct and perfused them with blood
collected from the same rats. Addi-
tionally, blood collected from rats
with acute pancreatitis (time-points: 2
and 6 h) was perfused in normal lungs.
Measurements and results: Tauro-
cholic acid injection induced a severe
pancreatic injury that started as early
as 2 h after the injection and persisted
without recovery over the 18-h study
period. In contrast, the pulmonary
injury was transient, appearing at the
6-h time point with recovery by the
end of the study. Pulmonary injury
was moderate and evidenced mostly
during lung reperfusion. Interestingly,
blood collected at the 2-h time point
in pancreatic rats induced pulmonary
injury in normal lungs while blood
collected at the 6-h time-point was
not toxic. Conclusions: While
pancreatic injury persists over the
full experimental period, pulmonary
injury is transient in our experimental
model. The recovery of lung injury by
18 h might be explained by a decrease
in the overall toxicity of pancreatic
blood over time.
Keywords Rats · Lung injury ·
Perfused lungs · Acute pancreatitis
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Introduction
During acute pancreatitis the incidence of pulmonary
complications varies from 15% to 55%, and their severity
ranges from mild hypoxemia without clinical or radio-
logical abnormalities to severe acute respiratory distress
syndrome [1, 2, 3]. The early phase of the pancreatic
disease is associated with a systemic inflammation while
the second is characterized by the appearance of local
complications such as fat necrosis, pseudocyst formation,
and pancreatic abscesses. Two peaks of pulmonary com-
plications during the early phase of acute pancreatitis have
been observed by Berry et al. [4]. The first one is observed
on hospital admission, and radiological abnormalities
have been found in 15% of patients while by day 5 new
radiological abnormalities are reported in additional 71%
patients of the study. However, the kinetics of pulmonary
complications in relation to the pancreatic disease is not
well established.
Moreover, the mechanisms of propagation of the dis-
ease from pancreas to lungs is largely unknown. Media-
tors released by the inflamed pancreas, the peripancreatic
tissues, or ascites have been administered in healthy ro-
dents to reproduce the lung injury observed in severe acute
pancreatitis. For example, trypsin [5, 6, 7] and elastase [5]
can reproduce lung injury in healthy rodents. Moreover,
ascites collected from rats with acute pancreatitis and in-
jected to normal rats also reproduce the injury [8, 9]. An-
other way to investigate the propagation of the pancreatic
disease to lungs might be to perfuse normal lungs with
blood collected from rats with acute pancreatitis. By col-
Fig. 1 Experimental protocol. To
investigate the time course of acute
pancreatitis-induced lung injury lungs
were reperfused either 2 h (AP2h,
n = 7), 6 h (AP6h, n = 9), or 18 h
(AP18h, n = 7) after taurocholic
injection. Sham operated rats were
studied at similar time points: 2 h
(SH2h, n = 5), 6 h (SH6h, n = 6), or
18 h (SH18h, n = 6). To assess the
effect of blood collected from rats
with acute pancreatitis on pulmonary
injury lungs isolated from normal rats
(control, C) were reperfused with
blood collected from rats 2 h
(C-AP2h, n = 8) or 6 h (C-AP6h, n = 8)
after induction of pancreatitis.
Conversely, lungs isolated from rats
with acute pancreatitis were
reperfused with blood collected from
normal rats: AP2h-NB (n = 10) or
AP6h-NB (n = 10). Lungs
immediately isolated from normal
rats were not subjected to laparotomy
and served as control group (n = 8).
AP Acute pancreatitis; Nl normal; PV
lung pressure-volume
lecting blood from pancreatic rats at various time points we
might be able to determine which phase of the pancreatic
disease is the more susceptible to induce injury in healthy
lungs.
We then studied the severity of acute pancreatitis-
associated lung injury over 18 h in rats that had tauro-
cholic acid injection in the pancreatic duct and determined
whether blood collected from rats with pancreatitis is
toxic enough to induce injury in normal lungs.
Methods
Induction of acute pancreatitis
Sprague-Dawley rats (350–400 g) were anesthetized with
isoflurane, intubated, and mechanically ventilated (FIO2
0.4) with a rodent ventilator (tidal volume 7 ml/kg; pos-
itive end-expiratory pressure, PEEP, 2.5 cm H2O; respira-
tory rate 70–80/bpm). After laparotomy the pancreatic duct
was cannulated with a PE-10 tubing. A clip was placed on
the duct close to the liver and taurocholic acid (4%, 0.5 ml
sodium salts; Sigma) was infused at a constant rate. The
clip was then withdrawn and the tubing was left in place,
the lower extremity being secured into the duodenum to al-
low a normal bile secretion. Before abdomen closure rats
had saline solution (5 ml) into the peritoneum. Rats re-
ceived buprenorphine and were looked after until lung iso-
lation (2, 6, or 18 h later; Fig. 1). Sham rats were similarly
anesthetized and ventilated and after laparotomy received
intraperitoneal fluid and buprenorphine injection. All pro-
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cedures were performed according to the guidelines stated
in the National Institutes of Health “Guide for the Care
and Use of Laboratory Animals.” The experimental proto-
col was reviewed and approved by the Ethics Committee
for Animal Research at the University Medical Center and
by the Veterinary Office in Geneva, Switzerland.
Lung isolation
One hour before lung reperfusion rats were anesthetized,
tracheotomized, ventilated, and monitored as previously
described. In addition, the femoral artery was cannulated
for blood sampling, continuous blood pressure monitoring,
and fluid replacement. Rats were anticoagulated and 25 ml
blood was gently withdrawn via the arterial cannula and
replaced by an equal volume of 6% hydroxyethyl starch to
maintain a mean systemic blood pressure above 50 mm Hg
to minimize lung ischemia (normovolemic hemodilution).
This blood volume was reconcentrated (hematocrit close to
30%) and used as a priming volume into the circuit. After
a median sternotomy a polyethylene catheter was placed
into the main pulmonary artery via the right ventricular
outflow track. Catheters were also placed into the left ven-
tricle for collection of effluent blood, and in the left atrium
for continuous left atrial pressure (Pla) recording. Follow-
ing pulmonary artery cannulation lungs were flushed with
30 ml cold (10°C) hydroxyethyl starch solution (perfusion
pressure 30 cm H2O) to minimize warm ischemia until ex
vivo reperfusion.
In vitro lung reperfusion
In a humidified Plexiglas chamber (37°C) the heart-lung
block was suspended to an isometric force displacement
transducer that continuously measures lung weight. Lungs
were ventilated with room air mixed with 5% CO2 at
a respiratory rate of 30/min, a tidal volume of 7 ml/kg,
and a PEEP of 2.7 cm H2O. Sighs were applied every
5 min (21 ml/kg). The circuit was primed with blood
volume collected from the same or from a different rat
(see protocol in Fig. 1). Lungs were then perfused via the
pulmonary artery cannula from an arterial reservoir placed
at a fixed height to induce a mean pulmonary arterial
pressure (Ppa) close to 17.5 mm Hg. Pulmonary blood
flow (PBF) was continuously measured by a transit-time
flowmeter. Effluent blood was drained through the left
ventricle cannula whose distal extremity was placed at
a height sufficient to obtain a Pla of 7.5 ± 0.5 mm Hg.
Assessment of lung function
Airway pressure (Paw), tidal volume, and airflow re-
sistance were measured. Continuous breath by breath
dynamic lung compliance (Cdyn) and expiratory airway
resistance (Raw) were assessed by the following formulas:
Cdyn = tidal volume/(peak Paw – PEEP) and Raw = (peak
Paw – PEEP)/maximal expiratory air flow. Inspiratory
and expiratory quasistatic pressure-volume curves were
performed before lung reperfusion and at the end of the
2-h reperfusion period by inflating and deflating lungs at
a constant rate (0.3 ml/s) from PEEP level to a volume
of 7 ml or 25 cm H2O (whichever occurred first) using
an automated infusion pump. The volumes obtained at
an inspiratory and expiratory Paw of 10 cm H2O were
recorded (V10insp and V10exp, respectively). Pulmonary
vascular resistance (PVR) was calculated by dividing
Ppa – Pla by PBF. Every 30 min a blood sample was
collected to measure blood gas, glucose and electrolyte
concentrations, and hematocrit. Total red and white
blood cell count and percentage of polymorphonuclear
cells (PMNs) were determined with an automated cell
counter. Amylase concentration was measured using an
automatized analyzer.
Wet-to-dry lung weight ratio
The inferior lobe of each lung was weighed (wet weight),
dried at 60°C for 2 days, and weighed again to determinate
the wet-to-dry lung weight ratio.
Experimental groups
To investigate the time course of acute pancreatitis-
induced lung injury in our experimental model lungs
were reperfused either 2 h (AP2h, n = 7), 6 h (AP6h,
n = 9), or 18 h (AP18h, n = 7) after taurocholic injection.
Sham-operated (SH) rats were studied at similar time
points: 2 h (SH2h, n = 5), 6 h (SH6h, n = 6), or 18 h (SH18h,
n = 6) (Fig. 1). To assess the effect of blood collected
from rats with acute pancreatitis on lung edema and
pulmonary mechanics lungs isolated from normal rats
(C) were reperfused with blood collected from rats 2 h
(C-AP2h, n = 8) or 6 h (C-AP6h, n = 8) after induction of
pancreatitis. Conversely, lungs isolated from rats with
acute pancreatitis were reperfused with blood collected
from normal rats: AP2h + NB (n = 10) or AP6h + NB
(n = 10). Finally, lungs immediately isolated from normal
rats served as a control group (control, n = 8).
Statistical analysis
Group data are presented as mean ± SE values. Statistical
comparison among the treatment groups at baseline or at
the end of the study was performed by a one-way analysis
of variance followed by Newman–Keuls multiple compari-
son test if the analysis of variance resulted in a p value less
1875
than 0.05, and comparisons involving time used a multi-
variate analysis of variance for repeated measurements.
Results
Taurocholic acid induced pancreatic injury
Induction of acute pancreatitis by taurocholic acid injec-
tion was well tolerated, and all animals rapidly recovered
from anesthesia. Rats had an increase in serum amylase
concentration as early as 2 h after taurocholic acid in-
jection, and high serum concentrations were maintained
6 h and 18 h after pancreatitis induction (Fig. 2). Hemo-
concentration, another marker of the disease, was absent
in the AP2h group but occurred in the AP6h and AP18h
groups (Fig. 3A). Hemoconcentration was associated
with a marked increase in the percentage of circulating
PMN cells (Fig. 3B). Alteration in blood gases or in
the alveolar-arterial O2 (A-aDO2) pressure gradient was
statistically significant only in the AP6h group (Fig. 3C).
Following lung isolation and before the start of
reperfusion the initial weight of heart-lung blocks (see
the15-min time point on Fig. 4A, B) did not differ between
the experimental groups. Serum amylase concentrations,
PMN cells, and pressure A-aDO2 gradient in the AP2h-NB
and AP6h-NB groups were similar to those in the respec-
tive AP groups, and in the C-AP2h and C-AP6h groups
similar to the control group (data not shown). In summary,
taurocholic acid injection induced a severe pancreatic
injury that started as early as 2 h after the injection while
systemic complications (hemoconcentration and increased
circulating PMNs) occurred at 6 h without recovery by
18 h. Lung injury was mild and transient; the A-aDO2
gradient increased only in the AP6h group. At the time of
Fig. 2 Serum amylase concentrations in control rats, sham-operated
rats (SH), and rats that had taurocholic acid injection in the pancre-
atic duct 2 h (AP2h), 6 h (AP6h), and 18 h (AP18h) before blood col-
lection; see Fig. 1 for experimental groups. **p < 0.01, ***p < 0.001
vs. control or SH groups (one-way analysis of variance followed by
Newman–Keuls test)
Fig. 3 Blood hematocrit (%, A), circulating polymorphonuclear
(PMN) cells (%, B), and alveolar-arterial O2 pressure gradient
(A-aDO2, C) in control rats, sham-operated (SH) rats, and rats with
acute pancreatitis (AP). Rats had sham operation or taurocholic
acid injection 2, 6, or 18 h before blood collection; see Fig. 1 for
experimental groups. *p < 0.05, **p < 0.01, ***p < 0.001 vs. control;
††p < 0.01, †††p < 0.001 vs. AP2h group; •p < 0.05, •••p < 0.001 vs.
SH6h group; xxp < 0.01, xxxp < 0.001 vs. SH18h group (one-way
analysis of variance followed by Newman–Keuls test).
lung isolation all experimental groups had similar heart-
lung weights. Laparotomy by itself increased circulating
PMNs (Fig. 3B) without any effect on hematocrit, serum
amylase, or the A-aDO2 pressure gradient.
Reperfusion of lungs with blood collected
from the same rat
We first perfused lungs isolated from normal, sham, and
pancreatic rats with blood collected from the same rats.
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Fig. 4 Lung weight recording
during reperfusion (A, B), final
weight gain (C), and final
wet/dry ratio (D) in AP2h (n = 7),
AP6h (n = 9), or AP18h (n = 7),
SH2h (n = 5), SH6h (n = 6), SH18h
(n = 6), or control (n = 8) groups;
see Fig. 1 for experimental
groups. *p < 0.05, **p < 0.01 vs.
control group; †p < 0.05 vs.
AP2h group; •p < 0.05 vs. SH6h
group; xp < 0.05 vs. AP18 group
(one-way analysis of variance
followed by Newman–Keuls
test)
During the 2-h reperfusion period Ppa, Pla, and PEEP
were maintained steady (± 10% from baseline values) as
described above. PBF, hematocrit, and pH did not change
significantly over time and did not differ between groups.
When lungs isolated from rats with acute pancreatitis
were reperfused with blood collected from the same rat
lung weight increased steadily over time (approx. 1 g/h)
only in the AP6h group (Fig. 4A). No weight increase
was observed in control and SH groups (Fig. 4B). The
final weight gain (Fig. 4C) and the final wet/dry ratio
(Fig. 4D) in the AP6h group were significantly higher
than in control, SH6h, and AP2h groups. The continuous
increase in weight over time during reperfusion was
Table 1 Lung volumes at 10 cm airway pressure at the beginning (15 min) and at the end (120 min) of the reperfusion period
Experimental Number V10insp (ml) V10exp (ml)
groups of rats 15 min 120 min 15 min 120 min
Control 8 6.04 ± 0.40 6.04 ± 0.47 6.96 ± 0.31 7.07 ± 0.42
SH2h 5 4.48 ± 0.34 5.29 ± 0.18 5.22 ± 0.40 6.06 ± 0.33
SH6h 6 5.43 ± 0.27 4.95 ± 0.26 6.72 ± 0.41 5.77 ± 0.39
SH18h 6 5.66 ± 0.50 5.07 ± 0.44 6.52 ± 0.64 5.93 ± 0.39
AP2h 7 5.62 ± 0.31 5.02 ± 0.18 6.78 ± 0.26 7.02 ± 0.40
AP6h 9 5.25 ± 0.40 2.97 ± 0.76**,† 5.87 ± 0.40 4.23 ± 0.71*
AP18h 7 5.32 ± 0.33 4.30 ± 0.72 6.08 ± 0.37 5.28 ± 0.71
Inspiratory (V10insp) and expiratory (V10exp) lung volume at 10 cmH2O airway pressure; *P < 0.05; **P < 0.01 versus control; †P < 0.05
versus SH6h. See Fig. 1 for experimental groups.
associated with a progressive and significant decrease
in Cdyn (p < 0.05 vs. SH6h; see Electronic Supplemen-
tary Material, ESM, S.F1A) and a significant increase
in Raw (ESM S.F1C). Furthermore, at the end of lung
reperfusion, the quasistatic pressure-volume relationship
was significantly altered in this group in comparison to
the SH6h group (Fig. 5B). The inspiratory (V10insp) and
expiratory (V10exp) lung volumes obtained at 10 cm H2O
pressure were significantly reduced in the PA6h group,
showing an important reduction in static compliance
(Table 1). No difference in lung pressure-volume curves
had been observed between groups at the start of reperfu-
sion.
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Fig. 5 Inspiratory and
expiratory pressure- volume
curves in isolated lungs
from sham rats (SH, open
symbols) and from rats with
pancreatitis (AP, closed
symbols). Lung reperfusion
was performed 2 h (A), 6 h
(B), or 18 h (C) after sham
operation or taurocholic
acid injection. AP2h (n = 7),
SH2h (n = 9), AP6h (n = 7),
SH6h (n = 5), AP18h (n = 6),
SH18h (n = 6); see Fig. 1 for
experimental groups
Reperfusion of pancreatic lungs with normal blood
Reperfusing lungs isolated from pancreatic rats (time
point: 6 h) with normal blood (PA6h-NB group) did not
modify the time course of dynamic lung mechanics, qua-
sistatic pressure-volume relationship, or final wet-to-dry
lung weight ratio in comparison to the AP6h group (ESM
S.F2; Fig. 6 and Table 2). Moreover, the increase in lung
weight was not attenuated (Fig. 6B, D). Furthermore, in
comparison to all other experimental groups the pul-
monary vascular resistances were significantly reduced
throughout the reperfusion period (p < 0.01, data not
shown). Pancreatic lungs reperfused with normal blood
(time point 2 h, PA2h-NB group) did not differ from time-
matched pancreatic lungs reperfused with their own blood
Table 2 Lung volumes at 10 cm airway pressure at the beginning (15 min) and at the end (120 min) of the reperfusion period
Experimental Number V10insp (ml) V10exp (ml)
groups of rats 15 min 120 min 15 min 120 min
AP2h + NB 10 5.84 ± 0.28 5.60 ± 0.33 6.35 ± 0.30 7.41 ± 0.19
C-AP2h 8 5.68 ± 0.29 4.07 ± 0.24**,†† 6.43 ± 0.34 6.08 ± 0.50
AP6h + NB 8 5.87 ± 0.15 2.88 ± 0.58** 6.77 ± 0.21 4.29 ± 0.50**
C-AP6h 8 5.39 ± 0.24 4.89 ± 0.40∈,$ 6.10 ± 0.24 5.72 ± 0.43
Inspiratory (V10insp) and expiratory (V10exp) lung volume at 10 cmH2O airway pressure; **P < 0.01 versus control (see Table 1); ††P < 0.01
versus AP2h + NB; /∈P < 0.05 versus AP6h + NB; $P < 0.05 versus AP6h (see Table 1). See Fig. 1 for experimental groups.
except for a small initial increase in lung weight during
the first minutes of reperfusion (Fig. 6A). In summary,
reperfusing pancreatic lungs with normal blood did not
attenuate lung injury.
Reperfusion of normal lungs with pancreatic blood
Reperfusing normal lungs with pancreatic blood collected
from rats 6 h after taurocholic acid injection (C-AP6h
group) produced no alteration in lung weight, dynamic
or static mechanics in comparison to the control group
(ESM S.F2; Fig. 6). The only abnormality was a reduced
Raw during the whole reperfusion period (ESM S.F2D). In
contrast, reperfusing normal lungs with pancreatic blood
collected 2 h after taurocholic acid injection (C-AP2h
group) was associated with a rapid initial increase in lung
weight (Fig. 6A), and the final weight gain was signifi-
cantly higher than in control group (Fig. 6C). A transient
increase in Cdyn was also observed in the first hour of
reperfusion, but Cdyn returned to baseline value by the
end of the reperfusion period (ESM S.F2A). This was
associated with a moderate but significant alteration in the
inspiratory pressure-volume relationship, as documented
by a significantly reduced V10insp (Table 2). In summary,
blood collected 2 h after taurocholic acid injection induces
moderate injury in normal lungs while blood collected 6 h
after the injection did not.
Discussion
Our study shows that taurocholic acid injection induces
a severe pancreatic injury that started as early as 2 h
after the injection and persisted without recovery over
the 18-h study period. In contrast, the pulmonary injury
is transient, appearing at 6 h with a complete recovery
by the end of the study. Pulmonary injury was mod-
erate and evidenced mostly during lung reperfusion.
Interestingly, blood collected at 2 h in pancreatic rats
induced pulmonary injury in normal lungs while blood
collected at the 6-h time point was not toxic. Thus while
pancreatic injury persisted over the full experimental
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Fig. 6 Weight during the 2-h
reperfusion period (A, B).
Experimental groups are: AP2h
(n = 7), AP2h-NB (n = 10),
C-AP2h (n = 8), control (n = 8),
AP6h (n = 9), AP6h-NB (n = 10),
C-AP6h (n = 8); see Fig. 1 for
experimental groups. Final
weight gain and final weight/dry
ratio (C, D) are showed in the
same experimental groups.
**p < 0.01 vs. control group;
†p < 0.05, ††p < 0.01 vs. the
C-AP6h group
period, pulmonary injury was only transient (Fig. 7). The
recovery of lung injury by 18 h might be explained by
a decrease in the overall toxicity of pancreatic blood over
time.
Fig. 7 Schematic representation of pancreatic injury (estimated by
serum amylase concentrations), lung injury (lung weight gain), and
blood toxicity (estimated by the lung weight gain induced by pan-
creatic blood perfusion in normal lungs)
Experimental models of acute pancreatitis
Several experimental models of acute pancreatitis with
variable severity and mortality rates have been described
in the literature to investigate the pathophysiology of
the disease. Intraperitoneal administration of supra-
maximal doses of cerulein (a cholecystokinin analog)
induced a mild edematous pancreatitis [10] while ad-
ministration of a cholin-deficient/ethionine-supplemented
diet to young female mice induced a necrotizing and
hemorrhagic pancreatitis, with death occurring within
5 days [11]. Intraductal injection of taurocholic acid
induced a severe disease with a high mortality within
hours of injection [12]. Pancreatic lesions with bacterial
infiltration were observed as early as day 1. By day 3
hemorrhagic necrosis, fat necrosis, cell infiltration, and in-
traparenchyma edema were observed in rats that survived.
Six hours after taurocholic acid administration Pereda
et al. [13] also observed acinar necrosis, interstitial edema,
and infiltrate of inflammatory cells. Another model that
combines glycodeoxycholic acid injection and cerulein
perfusion showed increase in myeloperoxidase activity
and pancreatic edema after 3 h, and the abnormalities
persisted by 24 h [6].
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Surprisingly, such severity was not found in our experi-
mental groups AP2h, AP6h, or AP18h. The absence of mor-
tality in our model might be explained by the fact that we
secured the lower extremity of the biliopancreatic tubing
into the duodenum after taurocholic acid injection, pre-
venting bile leak into the peritoneum. After taurocholic
acid injection the increase in serum amylase concentra-
tions occurred within 2 h without recovery by 18 h after
taurocholic acid injection. Hemoconcentration and inflam-
mation, evidenced by an increased circulating PMNs, oc-
curred later and persisted 18 h after taurocholic acid injec-
tion, demonstrating the persistent severity of the pancreatic
disease.
Characteristics of lung injury over time
Few previous studies investigated the early changes in pul-
monary mechanics after the initiation of acute pancreatitis
by taurocholic acid. In this model Lichtenstein et al. [12]
described alveolar edema by day 1 associated with PMNs
infiltration while Milani et al. [14] found a significant
increase in pulmonary elastance. In the latter study lung
sections showed uneven distribution of ventilation, edema
in alveoli, and PMN infiltration [14]. As early as 2 h
after bile acid injection, alveoli are filled with fluid,
macrophages, red blood cells, and cellular debris [15].
The enlargement of alveolar septa was evident and severe
endothelial changes were obvious with disintegration of
type I epithelial cells, adherence of platelets to capillary
endothelium, and loss of endothelial cell cytoplasm [15].
An increase in pulmonary wet-to-dry ratio was found
as early as 1 h after taurocholic acid injection [15]. Six
hours after taurocholic acid administration the infiltration
of PMNs was significantly increased, and alveola walls
were enlarged [13, 16]. Other experimental models have
also been used to study the time course and severity of
pulmonary injury. In cerulein-injected mice pulmonary
injury was characterized by an early but sustained edema
(within 12 h) associated with an increased pulmonary
microvascular permeability (within 36 h) [17]. In the
absence of complication pulmonary injury recovered
within 7 days [17].
In our experimental model lung injury was moderate
and transient. The A-aDO2 pressure gradient measured in
vivo (before lung isolation) increased 6 h after taurocholic
acid injection and returned to baseline value by 18 h. More-
over, before lung perfusion heart-lung weights were simi-
lar in SH, C, and AP rats. During reperfusion lung weight
steadily increased in the AP6h group in contrast to all
other groups whose weight remained within normal values.
In the AP6h group alteration in pulmonary mechanics was
also evidenced by an increase in Raw associated with a de-
crease in Cdyn. At 6 h pressure-volume curves were also
altered by lung reperfusion. Thus pulmonary injury in our
experimental model was minor, transient (6 h after tauro-
cholic acid injection), and evidenced mostly by lung reper-
fusion (Fig. 7).
Toxicity of pancreatic blood on normal lungs
Pulmonary injury has previously been reproduced by
injecting either pancreatic enzymes, ascites, or blood
collected from pancreatic animals in healthy rodents, but
no study has investigated whether ascites or blood toxicity
varies over time. Trypsin and trypsinogen perfusion in
healthy rats increased pulmonary edema and myeloper-
oxidase activity [6] while pancreatic elastase induced
cytokine-mediated lung injury through the nuclear factor
κ B second messenger system [5]. Ascites collected 24 h
after taurocholic acid administration in rats importantly
aggravated lung injury in rats with mild pancreatitis
(single cerulein injection) [18]. Sterile, endotoxin and
cytokine-free ascitic fluid collected from rats with gly-
codeoxycholic acid administration in the biliopancreatic
duct was infused in normal rats [9]. Twenty-four hours
after ascites injection alveolar leukocytes and protein
were significantly increased, and thickening of alveolar
septa was observed. Finally, serum with high trypsin
activity isolated from rats 6 h after glycodeoxycholic
acid and cerulein administration has been injected into
normal rats [7]. Increased alveolar edema and increased
myeloperoxidase activity characterized the lung injury.
When we reperfused normal lungs with pancreatic
blood collected from rats 6 h after taurocholic acid injec-
tion, no lung injury was observed. In contrast, reperfusing
normal lungs with pancreatic blood collected 2 h after
taurocholic acid injection was associated with a significant
weight gain, transient increase in Cdyn, and alterations in
the inspiratory pressure-volume relationship. We then hy-
pothesized that the decreased overall toxicity of pancreatic
blood over time would explain the recovery of lung injury
during pancreatic disease in our experimental model.
As described in human pancreatitis, the production of
anti-inflammatory cytokines over time is likely to limit the
toxic effects of activated enzymes and proinflammatory
mediators [19].
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